Sign in

CIK 0000818033 · Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
942875566
Phone
8582514400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-04-30 Collard Craig A Chief Executive Officer Option exercise · Restricted Stock Units −34,789 521,831
2025-04-19 Forbes William P EVP, Chief Development Officer Option exercise +3,875 110,872
2025-04-19 Forbes William P EVP, Chief Development Officer Option exercise · Restricted Stock Units −3,875 42,617
2025-04-19 Duarte Ira EVP, Chief Financial Officer Option exercise +3,875 124,455
2025-04-19 Duarte Ira EVP, Chief Financial Officer Option exercise · Restricted Stock Units +3,875 42,617
2025-04-19 Collard Craig A Chief Executive Officer Option exercise +13,796 391,163
2025-04-19 Collard Craig A Chief Executive Officer Option exercise · Restricted Stock Units −13,796 151,766
2025-04-03 Collard Craig A Chief Executive Officer Option exercise +62,500 377,367
2025-04-03 Collard Craig A Chief Executive Officer Option exercise · Restricted Stock Units −62,500 125,000
2025-01-31 Kaseta Michael Director Grant or award +17,950 55,829
2025-01-31 Kaseta Michael Director Grant or award · Stock Option (Right to Buy) +35,900 35,900
2025-01-31 Morgan Adam Director Grant or award +17,950 69,777
2025-01-31 Morgan Adam Director Grant or award · Stock Option (Right to Buy) +35,900 35,900
2025-01-31 Dissanaike Sharmila Director Grant or award +17,950 87,180
2025-01-31 Dissanaike Sharmila Director Grant or award · Stock Option (Right to Buy) +35,900 35,900
2025-01-31 Johnson Craig A Director Grant or award +17,950 83,770
2025-01-31 Johnson Craig A Director Grant or award · Stock Option (Right to Buy) +35,900 35,900
2025-01-31 Rodriguez Susan Director Grant or award +17,950 87,180
2025-01-31 Rodriguez Susan Director Grant or award · Stock Option (Right to Buy) +35,900 35,900
2025-01-31 Christian Waage Director Grant or award +17,950 84,130

Page 9 of 28 · 557 trades